DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
LEMAITRE VASCULAR INC Medical devices & implants for surgeons treating peripheral vascular disease in open surgery.	United States of America	LMAT
Lifecare ASA Developing implantable CGM nanosensors for human & veterinary diabetes management.	Norway	LIFE
Lifeward Ltd. Develops robotic technologies for physical rehabilitation, gait training, and mobility support.	United States of America	LFWD
L&K BIOMED CO., LTD. Global developer and manufacturer of innovative orthopedic spinal implants and fixation systems.	South Korea	156100
MANI, INC. Global manufacturer of surgical, ophthalmic, and dental instruments for healthcare professionals.	Japan	7730
MATERIALISE NV Global provider of 3D printing software and services for industrial and healthcare sectors.	United States of America	MTLS
MAXCYTE, INC. Provides a scalable, non-viral electroporation platform for cell therapy development.	United States of America	MXCT
Medacta Group SA Designs and distributes orthopedic & neurosurgical devices for joint, spine, and sports medicine.	Switzerland	MOVE
Medartis Holding AG Global provider of high-precision implants & instruments for surgical fracture fixation.	Switzerland	MED
Media Lab Develops IT solutions for the dental sector, specializing in computer-guided implant surgery.	Italy	MLLAB